Devatis Demonstrated a Strong Presence at Major Congresses in Switzerland

Devatis took part in both the Swiss Society of Dermatology and Venereology (SGDV) Congress held in St. Gallen on September 3–5, and the Annual Congress of the Swiss Society of Rheumatology & HPR Symposium in Interlaken on September 4–5. At these two significant events, Devatis engaged with healthcare professionals from across Switzerland, shared therapeutic solutions, and contributed to scientific dialogue.

The congresses were marked by strong interaction and high-level participation. On the opening day of the SGDV Congress, Devatis Chairman & CEO Philipp Haas was interviewed by leading representatives of the Swiss healthcare media. Overall, both events offered a valuable opportunity to connect with professionals, exchange ideas, and highlight Devatis’ expanding portfolio.

Since 2018, Devatis has steadily expanded its presence in Switzerland, upholding the principles of quality, accessibility, and long-term partnership. Participation in these congresses once again underlines the company’s growing footprint and its dedication to providing value to the Swiss healthcare ecosystem.

For Devatis, such platforms represent not only opportunities to follow scientific developments, but also strategic moments to strengthen communication and collaboration with healthcare professionals. Through its presence at these two congresses, Devatis has further reinforced its role as a reliable and forward-looking contributor to the Swiss healthcare system.